ALPHABET study

Not Applicable

• Conditions: Overactive bladder with benign prostatic hyperplasia; OAB BPH

• Registration Number: JPRN-jRCT1011230058
• Lead Sponsor: Wada Naoki

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-01-26
• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Male
• Target Recruitment: 60

Inclusion Criteria

Age over 40
Prostate volume less than 30ml
OAB
Postvoid residual less than 100ml
Patients who agree with the research

Exclusion Criteria

Postvoid residual over 100ml
suspected of prostate cancer
any medicationfor LUTS within 8 weeks
patients with neurogenic disease
patients with active urinary infection
patients with hypotension
patients with severe heart disease
patients with severe liver disease
pateints with severe kidney disease
patients with allergy with tamsulocin/vibegron

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
OABSS

Secondary Outcome Measures

Name	Time	Method
IPSS postvoid residual